EUVIMEDEUVIMED entdecken
Crossref

Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer

Ameya D Puranik, Sayak Choudhury, Suchismita Ghosh, Indraja D Dev, Varun Ramchandani, Abhishek Uppal, Vikrant Bhosale, Abhishek Palsapure, Rachita Rungta, Rakesh Pandey, Shweta Khatri, Gemson George und 6 weitere

Indian Journal of Cancer · 2024

DOI: 10.4103/ijc.ijc_52_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Cancer, 2024. Verfasst von Ameya D Puranik und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital and Advanced Centre for Treatment, Research and Education in Cancer (ACT…. Hauptthemen laut MEDLINE: Nuclear Medicine, Neoplasms. Die Arbeit nennt 262 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it’s way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear MedicineNeoplasmsHumansPositron Emission Tomography Computed TomographyPositron-Emission TomographyRadiopharmaceuticalsRadioisotopesFluorodeoxyglucose F18

Substanzen

RadiopharmaceuticalsRadioisotopesFluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, Maharashtra, India.

Zitieren

APA

Puranik, A. D., Choudhury, S., Ghosh, S., Dev, I. D., Ramchandani, V., Uppal, A., Bhosale, V., Palsapure, A., Rungta, R., Pandey, R., Khatri, S., George, G., Satamwar, Y., Maske, R., Agrawal, A., Shah, S., Purandare, N. C., & Rangarajan, V. (2024). Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer. Indian Journal of Cancer. https://doi.org/10.4103/ijc.ijc_52_24

Vancouver

Puranik AD, Choudhury S, Ghosh S, Dev ID, Ramchandani V, Uppal A, et al. Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer. Indian Journal of Cancer. 2024. doi:10.4103/ijc.ijc_52_24

BibTeX
@article{Puranik2024,
  author = {Puranik, Ameya D and Choudhury, Sayak and Ghosh, Suchismita and Dev, Indraja D and Ramchandani, Varun and Uppal, Abhishek and Bhosale, Vikrant and Palsapure, Abhishek and Rungta, Rachita and Pandey, Rakesh and Khatri, Shweta and George, Gemson and Satamwar, Yogesh and Maske, Rahul and Agrawal, Archi and Shah, Sneha and Purandare, Nilendu C and Rangarajan, Venkatesh},
  title = {Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer},
  journal = {Indian Journal of Cancer},
  year = {2024},
  doi = {10.4103/ijc.ijc_52_24}
}
Kostenlos starten →